Sun Pharmaceutical Industries, Inc. recalls DOXOrubicin Hydrochloride Liposome Injection, 20 mg/10 ml (2 mg/mL), 10 mL Single Use Vial, Distributed by: Sun Pharmace
Recalled January 31, 2018 · FDA recall D-0229-2018 · Sun Pharmaceutical Industries
Hazard
Lack Of Assurance Of Sterility · FDA Class II
Units
393 vials
Sold at
Product was distributed nationwide in the USA
Description
Lack Of Assurance Of Sterility
Product
DOXOrubicin Hydrochloride Liposome Injection, 20 mg/10 ml (2 mg/mL), 10 mL Single Use Vial, Distributed by: Sun Pharmaceutical Industries , Inc. Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway. Halol-389 350, Gujarat, India. NDC 47335-049-40
Manufacturer(s)
Sun Pharmaceutical Industries, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →